Therapeutic approaches in adults with congenital heart disease-associated pulmonary arterial hypertension
Open Access
- 30 November 2010
- journal article
- review article
- Published by European Respiratory Society (ERS) in European Respiratory Review
- Vol. 19 (118) , 300-307
Abstract
Pulmonary arterial hypertension is a major contributor to reduced functional capacity in patients with congenital heart disease. Expert care is essential. Whilst careful supportive management has traditionally been the mainstay for these patients, in recent times significant improvements in exercise capacity and even survival have been observed with the use of disease-targeted therapy, including endothelin receptor antagonists, phosphodiesterase inhibitors and prostanoids. In this review we will discuss current therapeutic options and summarise the recent literature on disease-targeted therapy.Keywords
This publication has 67 references indexed in Scilit:
- Acute vasodilator effects of inhaled fasudil, a specific Rho-kinase inhibitor, in patients with pulmonary arterial hypertensionHeart and Vessels, 2010
- Long-term effect of bosentan in adults versus children with pulmonary arterial hypertension associated with systemic-to-pulmonary shunt: Does the beneficial effect persist?American Heart Journal, 2007
- Role of oral sildenafil in severe pulmonary arterial hypertension: Clinical efficacy and dose response relationshipInternational Journal of Cardiology, 2006
- A randomized, placebo-controlled, double-blind, crossover study to evaluate the efficacy of oral sildenafil therapy in severe pulmonary artery hypertensionAmerican Heart Journal, 2006
- Adult patients with congenital heart disease and pulmonary arterial hypertension: First open prospective multicenter study of bosentan therapyAmerican Heart Journal, 2005
- New predictors of outcome in idiopathic pulmonary arterial hypertensionThe American Journal of Cardiology, 2005
- Safety and tolerability of bosentan in adults with Eisenmenger physiologyInternational Journal of Cardiology, 2005
- Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology.2004
- Initial experience with bosentan therapy in patients with the Eisenmenger syndromeThe American Journal of Cardiology, 2004
- Cerebrovascular Accidents with Tetralogy of FallotArchives of Pediatrics & Adolescent Medicine, 1961